Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q3 2023 Earnings Call Transcript November 9, 2023 Eton Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.02, expectations were $-0.1. Operator: Good afternoon, and welcome to the Eton Pharmaceuticals Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please be advised that this call is being recorded at the company’s […]
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q2 2023 Earnings Call Transcript August 10, 2023 Eton Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.15, expectations were $-0.09. Operator: Good afternoon, and welcome to Eton Pharmaceuticals Second Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please be advised that this call is being recorded at the company’s request. […]
Operator: Good afternoon and welcome to the Eton Pharmaceuticals First Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen only mode.
Eton Pharmaceuticals Inc (ETON) Announces FDA Approval of ZONISADE streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Fourth Quarter 2021 Revenue of $6.1 millionFourth Quarter 2021 Net Income of $1.0 million and EPS of $0.04 DEER PARK, Ill., March 16, 2022 Eton Pharmaceuticals, Inc , an innovative. | March 16, 2022